This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mowszowicz, I. Articles by Mauvais-Jarvis, P. Search for Related Content PubMed PubMed Citation Articles by Mowszowicz, I. Articles by Mauvais-Jarvis, P.

Androgen Binding Capacity and 5-Reductase Activity in Pubic Skin Fibroblasts from Hirsute Patients^*

Department of Biochemistry, Faculte de Medecine Pitie-Salpetriere (I.M., E.M., A.D., F. W.J, and the Department of Reproductive Endocrinology, Faculte de Medecine Necker-Enfants Malades (F.K., P.M.-J.), Paris, France

Address all correspondence and requests for reprints to: I. Mowszowicz, Faculte de Medecine Pitie-Salpetriere, Service de Biochimie, 91 Boulevard de l'Hopital, 75634 Paris Cedex 13, France.

We have measured the total (cytosolic plus nuclear) androgen binding capacity of pubic skin fibroblasts from nine patients with hirsutism of various origin. Confluent intact cell monolayers were incubated with increasing concentrations (0.05–2 nM) of [³H]dihydrotestosterone ([³H]DHT) with or without a 200-fold excess of unlabeled DHT. The androgen binding capacities (mean ± SD) were similar in normal men (411 ± 171 fmol/mg DNA), women (310 ± 103 fmol/mg DNA), and hirsute patients (313 ± 141 fmol/mg DNA) regardless of the plasma androgen levels. In contrast, the 5-reductase level in pubic skin fibroblasts (mean ± SD) was, as previously described, higher in hirsute women (3.3 ± 2.6 fmol/µg DNA·h) than in normal women (1.1 ± 0.6 fmol/µg DNA·h; P < 0.05). We conclude from these data that: 1) increased androgen binding capacity cannot be held responsible for hypersensitivity to androgens in hirsutism; 2) the androgen receptor is not regulated by androgens in human skin, as similar levels are observed in men, women, and hirsute patients; 3) this contrasts with 5-reductase activity and emphasizes the importance of this enzyme as an amplifier of androgen action in areas where it is stimulated by androgens, such as pubic skin. (J Clin Endocrinol Metab 56: 1209, 1983)

^* This work was supported by CNRS (ATP Endocrinologie) and D.G.R.S.T. (Grant 79.7.1218).

Received September 9, 1982.

This article has been cited by other articles:

				M. Fassnacht, N. Schlenz, S. B. Schneider, S. A. Wudy, B. Allolio, and W. Arlt Beyond Adrenal and Ovarian Androgen Generation: Increased Peripheral 5{alpha}-Reductase Activity in Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2760 - 2766. [Abstract] [Full Text] [PDF]

				R. Azziz, E. Carmina, and M. E. Sawaya Idiopathic Hirsutism Endocr. Rev., August 1, 2000; 21(4): 347 - 362. [Abstract] [Full Text] [PDF]

				R. M. Calvo, M. Asunción, J. Sancho, J. L. San Millán, and H. F. Escobar-Morreale The Role of the CAG Repeat Polymorphism in the Androgen Receptor Gene and of Skewed X-Chromosome Inactivation, in the Pathogenesis of Hirsutism J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1735 - 1740. [Abstract] [Full Text]

				E. Diamanti-Kandarakis, G. Tolis, and A. J. Duleba Androgens and Therapeutic Aspects of Antiandrogens in Women Reproductive Sciences, July 1, 1995; 2(4): 577 - 592. [Abstract] [PDF]

				A. W. Lucky Androgens and the Skin: Another Journey Around the Circle Arch Dermatol, February 1, 1987; 123(2): 193 - 195. [Abstract] [PDF]

				R. S. RITTMASTER and D. L. LORIAUX Hirsutism Ann Intern Med, January 1, 1987; 106(1): 95 - 107. [Abstract] [PDF]